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a b s t r a c t
Brachial artery Flow Mediated Dilation (FMD) is widely used as a
non-invasive measure of endothelial function. Adherence to expert
consensus guidelines on FMD measurement has been found to be
of vital importance to obtain reproducible data. This article lists
the literature data which was considered in the development of a
tool to aid in the objective judgement of the extent to which
published studies adhered to expert guidelines for FMD mea-
surement. Application of this tool in a systematic review of FMD
studies (http://dx.doi.org/10.1016/j.atherosclerosis.2016.03.011)
(Greyling et al., 2016 [1]) indicated that adherence to expert
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Reproducibility
Methodology
consensus guidelines is strongly correlated to the reproducibility of
FMD data.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Speciﬁcations Table
Subject area Medicine
More speciﬁc sub-
ject area
Vascular Physiology
Type of data Table
How data was
acquired
Systematic literature survey and expert consensus
Data format Processed
Experimental factors Methodological parameters related to valid measurement FMD
Experimental
features
Assessment tool based on 33 studies pertaining to the most appropriate
methods to assess FMD in humans identiﬁed from literature and expert
guidelines for FMD measurement
Data source location Nijmegen, The Netherlands
Data accessibility Data is within this article
Value of the data
 The literature data provided here establishes an evidence base and a physiological background
rationale for the individual components included in the Adherence Score, aiding in the improve-
ment of the practical guidance and technical approaches to FMD measurement and analysis.
 This “Adherence Score” which ranges between 0 (i.e. no adherence) and 10 (i.e. full adherence) can
conceivably be employed to evaluate the perceived quality of studies reporting FMD data, with a
higher outcome of this measure being strongly related to better reproducibility of the FMD data [1].
 This tool may prove useful additional information when pooling, contrasting and comparing dif-
ferent studies, e.g. for the purpose of meta-analyses or systematic reviews.
1. Data
A tool to enable objective assessment of the level adherence to the FMD guidelines was developed.
Table 1 presents the 19 different factors that make up the “Adherence Score” tool along with citations
to the literature data which justify the inclusion of each factor in question.
2. Experimental design, materials and methods
Based on previous expert-consensus guidelines [35], we devised a scoring system reliant on the
reporting of 19 different methodological factors related to FMD measurement. These factors were
identiﬁed after critical review and appraisal of published physiological studies pertaining to the most
appropriate methods to assess FMD in humans. Values were assigned to each component propor-
tional to its perceived importance for valid assessment of the FMD. This was done through expert
consensus discussion within the Working Group (AG, LG and DHJT). The “Adherence Score” that any
A. Greyling et al. / Data in Brief 8 (2016) 73–7774
given study can be assigned ranges from 0 to 10 points depending on how many of the 19 different
factors that are reported or referred to in the text of the paper in question.
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Table 1
Scoring tool based on currently accepted guidelines for the assessment of the perceived quality of FMD studies [2–34].
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Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.05.011.
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